BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma - Katja Gutmair; Diego Villa; Nicholas Cunningham; Elisabeth Silkenstedt; Lisa Rimsza; Colleen Ramsower; David W. Scott; Alina S. Gerrie; Hanneke C. Kluin-Nelemans; Martin Dreyling; Eva Hoster (Blood Advances)